Cipla Chief: Don’t Dilute India’s Patent Laws
This article was originally published in PharmAsia News
Executive Summary
Cipla's chairman and anti-monopoly champion, Yusuf Hamied, has re-emphasized concerns around any potential dilution of India's patent regulations, given the possible ripple effects across the developing world.